Tony J Wang

US Patent:

8478913, Jul 2, 2013

Filed:

Nov 16, 2012

Appl. No.:

13/680000

Inventors:

Daniel J. Fritchman - Sunnyvale CA, US
Scott Krueger - San Francisco CA, US
Terry Tikalsky - Sunnyvale CA, US
Debra A. Sillman - Mountain View CA, US
Tony Chi Wang Ng - Santa Clara CA, US

Assignee:

Apple Inc. - Cupertino CA

International Classification:

G06F 13/12

US Classification:

710 62, 710 72, 340 58, 713300

Abstract:

An adapter for connecting an accessory to a portable electronic device includes a first connector compatible with a connector of the portable electronic device and a second connector compatible with a connector of the accessory. The connectors of the accessory and the portable electronic device are otherwise incompatible with each other. The adapter provides two levels of authentication. First, the adapter authenticates itself to the portable electronic device. If this first authentication is successful, then the adapter authenticates the accessory to the adapter.

US Patent:

20110243942, Oct 6, 2011

Filed:

Apr 4, 2011

Appl. No.:

13/079262

Inventors:

Tony Wang - Sunnyvale CA, US

Assignee:

ATHENA DISCOVERY, INC. - Sunnyvale CA

International Classification:

A61K 39/395
C07K 19/00
A61K 39/44
C12N 5/10
C12N 15/03
A61P 9/00
A61P 17/02

US Classification:

4241341, 5303873, 536 234, 435325, 4353201

Abstract:

Disclosed are human relaxin-Fc fusion proteins having an increased serum half-life, polynucleotides encoding the same, and intermediates formed during the fusion protein biosynthesis. The fusion proteins may include a linker portion or other sections as well. Suitable fusion proteins are also those predicted to have the same effect as human relaxin in vivo, based, for example, on structural modeling. The fusion protein is useful in the treatment of a number of diseases and conditions, including heart disease, vascular disease, wound healing, fibrosis, fibromyalgia, and promoting angiogenesis.

US Patent:

20110243943, Oct 6, 2011

Filed:

Apr 4, 2011

Appl. No.:

13/079609

Inventors:

Tony Wang - Sunnyvale CA, US

Assignee:

ATHENA DISCOVERY, INC. - Sunnyvale CA

International Classification:

A61K 39/395
A61P 9/00
A61P 9/04
A61P 25/28
A61P 17/02
A61P 9/10
A61P 31/00
A61P 9/12
A61P 13/12
A61P 1/02
A61P 11/00

US Classification:

4241341

Abstract:

Disclosed are human relaxin-Fc fusion proteins having an increased serum half-life, polynucleotides encoding the same, and intermediates formed during the fusion protein biosynthesis. The fusion proteins may include a linker portion or other sections as well. Suitable fusion proteins are also those predicted to have the same effect as human relaxin in vivo, based, for example, on structural modeling. The fusion protein is useful in the treatment of a number of diseases and conditions, including heart disease, vascular disease, wound healing, fibrosis, fibromyalgia, and promoting angiogenesis.

US Patent:

20110245469, Oct 6, 2011

Filed:

Apr 4, 2011

Appl. No.:

13/079570

Inventors:

Tony Wang - Sunnyvale CA, US

Assignee:

ATHENA DISCOVERY, INC. - Sunnyvale CA

International Classification:

C07K 16/00

US Classification:

5303873

Abstract:

Disclosed are human relaxin-Fc fusion proteins having an increased serum half-life, polynucleotides encoding the same, and intermediates formed during the fusion protein biosynthesis. The fusion proteins may include a linker portion or other sections as well. Suitable fusion proteins are also those predicted to have the same effect as human relaxin in vivo, based, for example, on structural modeling. The fusion protein is useful in the treatment of a number of diseases and conditions, including heart disease, vascular disease, wound healing, fibrosis, fibromyalgia, and promoting angiogenesis.

US Patent:

20110250215, Oct 13, 2011

Filed:

Apr 4, 2011

Appl. No.:

13/079596

Inventors:

Tony Wang - Sunnyvale CA, US

Assignee:

ATHENA DISCOVERY, INC. - Sunnyvale CA

International Classification:

A61K 39/395
C08F 8/32
C12N 9/96
A61P 9/04
A61P 17/02
A61P 9/12
A61P 31/00
A61P 29/00
A61P 9/10
C07K 19/00
A61P 25/00

US Classification:

4241781, 5303917, 5303919, 525 541, 435188

Abstract:

Disclosed are human relaxin-Fc fusion proteins having an increased serum half-life, polynucleotides encoding the same, and intermediates formed during the fusion protein biosynthesis. The fusion proteins may include a linker portion or other sections as well. Suitable fusion proteins are also those predicted to have the same effect as human relaxin in vivo, based, for example, on structural modeling. The fusion protein is useful in the treatment of a number of diseases and conditions, including heart disease, vascular disease, wound healing, fibrosis, fibromyalgia, and promoting angiogenesis.

US Patent:

20140073188, Mar 13, 2014

Filed:

Dec 31, 2012

Appl. No.:

13/731634

Inventors:

Tony Chi Wang Ng - Santa Clara CA, US
Jeffrey J. Terlizzi - San Francisco CA, US
Scott Krueger - San Francisco CA, US

Assignee:

Apple Inc. - Cupertino CA

International Classification:

H01R 31/06

US Classification:

43962021

Abstract:

An adapter for providing connectivity between a host connector of a host device and an accessory connector of an accessory that is incompatible with the host connector is described. The adapter can include a host interface connector that is compatible with the host connector, and an accessory interface connector that is compatible with the accessory connector of the accessory. The adapter may further include an identification module that can provide adapter identification information to a host device connected to the host interface connector, and may also include an authentication module that can authenticate an accessory connected to the accessory interface connector.

US Patent:

20140075061, Mar 13, 2014

Filed:

Sep 7, 2012

Appl. No.:

13/607443

Inventors:

Daniel J. Fritchman - Sunnyvale CA, US
Tony Chi Wang Ng - Santa Clara CA, US
Jeffrey J. Terlizzi - San Francisco CA, US
Scott Krueger - San Francisco CA, US

Assignee:

Apple Inc. - Cupertino CA

International Classification:

G06F 13/38

US Classification:

710 62

Abstract:

An adapter for providing connectivity between a host connector of a host device and an accessory connector of an accessory that is incompatible with the host connector is described. The adapter can include a host interface connector that is compatible with the host connector, and an accessory interface connector that is compatible with the accessory connector of the accessory. The adapter may further include an identification module that can provide adapter identification information to a host device connected to the host interface connector, and may also include an authentication module that can authenticate an accessory connected to the accessory interface connector.

US Patent:

20200053729, Feb 13, 2020

Filed:

Aug 6, 2019

Appl. No.:

16/532995

Inventors:

- Cupertino CA, US
Oren Shani - Saratoga CA, US
Christiaan A. Hartman - Mountain View CA, US
Yong Liu - Campbell CA, US
Charles F. Dominguez - Redwood City CA, US
Karthik R. Mekala - Santa Clara CA, US
Tashbeeb Haque - San Francisco CA, US
Lawrie Kurian - San Jose CA, US
Mete Fikirlier - Mountain View CA, US
Guoqing Li - Campbell CA, US
Rajneesh Kumar - San Jose CA, US
Ka Ho P. Poon - San Jose CA, US
Brian B. Whitaker - Los Gatos CA, US
Joseph Hakim - Soquel CA, US
John A. Wilson - San Francisco CA, US
Tony Chi Wang Ng - Saratoga CA, US
Roopkumar Parthasarathy Rao - Cupertino CA, US
Curtis J. Schmidek - Los Altos CA, US
Shishir Gupta - San Jose CA, US
Tushar R. Shah - Cupertino CA, US
Jacob H. Power - Santa Clara CA, US
Bryan J. Follis - San Mateo CA, US
Anand Rajagopalan - Saratoga CA, US

International Classification:

H04W 72/04
H04W 72/12

Abstract:

An interface circuit in an electronic device may contend for access to a shared communication channel on behalf of the electronic device and a recipient electronic device, where the access has a duration. Then, the electronic device may provide a schedule frame intended for the recipient electronic device that includes information that specifies one or more time slots during the duration that are associated with the recipient electronic device and one or more communication functions of the recipient electronic device in the one or more time slots. Moreover, the electronic device may provide a data frame with data intended for the recipient electronic device. In response, the electronic device may receive a response frame associated with the recipient electronic device, where the response frame is received during at least one of the one or more time slots.